Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is a real momentum stock, the stock has been booming recently, and may keep doing so in the near future. Bristol-Myers Squibb Company is not very popular among insiders. Bristol-Myers Squibb Company is a mediocre stock to choose.

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, d...

News

AGF Management Ltd. Sells 21,187 Shares of Bristol-Myers Squibb (NYSE:BMY)

Zolmax AGF Management Ltd. decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...\n more…

Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024

Business Wire Bristol Myers Squibb (NYSE: BMY) will announce results for the third quarter of 2024 on Thursday, October 31, 2024. Company executives will review financial results and address inquiries from...\n more…

First Foundation Advisors Has $235,000 Position in Bristol-Myers Squibb (NYSE:BMY)

Ticker Report First Foundation Advisors raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 73.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The...\n more…

Bristol-Myers Squibb Company (NYSE:BMY) is favoured by institutional owners who hold 77% of the company

Simply Wall St Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable...\n more…

Bristol-Myers Squibb Company PFD CONV 2 declares $0.50 dividend

SeekingAlpha.com: All News no summary\n more…

Bristol-Myers Squibb declares $0.60 dividend

SeekingAlpha.com: All News Bristol-Myers Squibb Company (BMY) declared $0.60/share quarterly dividend, in line with previous. It is payable Nov. 1 to shareholders of record Oct. 4.\n more…